Editas Medicine (EDIT) Change in Acquisitions & Divestments (2017 - 2025)

Editas Medicine (EDIT) has 9 years of Change in Acquisitions & Divestments data on file, last reported at $40.0 million in Q3 2025.

• Change in Acquisitions & Divestments for Q3 2025 came in at $40.0 million, down 53.96% year-over-year; the trailing twelve-month figure through Sep 2025 was $170.5 million (down 48.11% YoY), and the FY2024 annual result was $257.2 million, down 0.89% from the prior year.
• Change in Acquisitions & Divestments fell to $40.0 million in Q3 2025 per EDIT's latest filing, from $42.5 million in the prior quarter.
• Over five years, Change in Acquisitions & Divestments peaked at $130.8 million in Q1 2021 and troughed at $31.5 million in Q4 2024.
• A 5-year average of $76.4 million and a median of $74.2 million in 2021 frame the typical range for Change in Acquisitions & Divestments.
• The sharpest annual moves came in 2021 and 2024: Change in Acquisitions & Divestments surged 176.48% in 2021, then sank 69.39% in 2024.
• A 5-year view of Change in Acquisitions & Divestments shows it stood at $84.3 million in 2021, then decreased by 6.91% to $78.5 million in 2022, then jumped by 31.08% to $102.9 million in 2023, then slumped by 69.39% to $31.5 million in 2024, then gained by 27.03% to $40.0 million in 2025.
• Business Quant data shows EDIT's Change in Acquisitions & Divestments at $40.0 million in Q3 2025, $42.5 million in Q2 2025, and $56.5 million in Q1 2025.